Miragen Therapeutics Gains 32.23%
Tue, Nov 17, 2020 at 05:30 PM
Miragen Therapeutics (MGEN:NASDAQ) rocketted at $20.84, representing a gain of 32.2%. On Mon 16 Nov 20, MGEN:NASDAQ touched a New 2-Week Intraday Low of $15.48. The stock appeared on our News Catalysts scanner on Tue 10 Nov 20 at 06:51 PM in the 'INVESTOR UPDATE' category. From Mon 02 Nov 20, the stock recorded 30.00% Up Days and 63.64% Green Days
The stock spiked on Fri 30 Oct 20 at $23.46 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Miragen Therapeutics (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- Phoenix Tree Holdings Limited (DNK:NYSE), 75.18%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 49.55%
- Riot Blockchain, Inc. (RIOT:NASDAQ), 48.41%
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 40.31%
- Gannett Co., Inc. (GCI:NYSE), 32.76%
- Miragen Therapeutics (MGEN:NASDAQ), 32.23%
- Nxt-ID, Inc. (NXTD:NASDAQ), 29.89%
- Net Element, Inc. (NETE:NASDAQ), 25.03%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 25%
- Evogene Ltd. (EVGN:NASDAQ), 24.48%